节点文献

鸡α干扰素基因的克隆、原核表达及抗病毒效果研究

Cloning,Prokaryotic Expression of Chicken Interferon-α Gene and Study on Antiviral Effect of Recombinant Chicken Interferon-α

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 韦琴彭贵青金梅林朱裕东周红波郭红燕陈焕春

【Author】 WEI Qin,PENG Gui-Qing,JIN Mei-Lin*,ZHU Yu-Dong,ZHOU Hong-Bo,GUO Hong-Yan and CHEN Huan-ChunLab of Animal Virus,State Key Laboratory of Agricultural Microbiology,Huazhong Agricultural University,Wuhan 430070,China

【机构】 华中农业大学农业微生物学国家重点实验室动物病毒室华中农业大学农业微生物学国家重点实验室动物病毒室 武汉430070武汉430070

【摘要】 通过PCR从三黄肉鸡的肝脏基因组中扩增了鸡α干扰素(ChIFN-α)全长基因。序列分析表明ChIFN-α基因全长582bp,亚克隆其成熟蛋白编码基因(489bp),利用基因重组技术构建了E.coli/pET-28a(+)-IFNα,使IFN-α置于pET-28a的T7启动子下游并同6×His(多聚组氨酸标签)-Tag融合。经酶切鉴定,DNA测序证实重组质粒构建正确;将重组质粒转化大肠杆菌BL21(DE3),IPTG诱导表达,SDS-PAGE,Western-blot分析证实表达出22kD左右的融合蛋白,表达的蛋白以不溶性的包涵体形式存在并且具有良好的免疫学活性。提纯的包涵体纯度可达70%以上,用镍亲和层析方法纯化蛋白则可达到95%。经透析复性后的蛋白在鸡胚成纤维细胞上能够抑制H9N2禽流感病毒的复制。鸡胚试验中重组干扰素抗病毒效果好在H9N2禽流感病毒攻毒组中,能保护鸡胚并使其孵出率达到100%的重组干扰素最小蛋白含量为2μg;重组干扰素对新城疫病毒复制也有一定的抑制能力,延迟该病毒复制时间为12h至48h;雏鸡试验表明重组干扰素也能较好地抵抗H9N2禽流感病毒对雏鸡的感染。两组试验均表明,亲和层析纯化蛋白是包涵体蛋白活性的20倍左右。

【Abstract】 The full length of chicken interferon alpha (ChIFN-α)gene was amplified by the polymerase chain reaction(PCR) from total liver genome of Sanhuang meat-chicken and sequenced. The amplified gene was about 582bp. The coding region for mature protein (489bp) was subcloned into pET-28a(+). The recombinant plasmid pET-28a(+)-IFNα was identified by enzyme digestion and DNA sequencing. Data of SDS-PAGE and Western-blot indicated that a 22kD fusion protein was expressed in the form of inclusion bodies with good immunity. The purity of inclusion bodies was above 70% and that of protein purified by nickel affinity chromatography was 95%. The recombinant protein could inhibit H9N2 avian influenza virus (H9N2 AIV) replication on chick embryo fibroblast. 2μg of recombinant IFN-α could completely protect Chick embryo from H9N2 AIV infection. The recombinant IFN-α can also delay Newcastle disease virus (NDV) replication on chick embryo for 12~48h. Chicken administered recombinant IFN-α can resist the H9N2 AIV infection. The bioactivities of recombinant IFN-α purified by affinity chromatograph were 20 times higher than that of inclusion bodies.

  • 【文献出处】 生物工程学报 ,Chinese Journal of Biotechnology , 编辑部邮箱 ,2006年05期
  • 【分类号】S852.4;Q789
  • 【被引频次】32
  • 【下载频次】534
节点文献中: 

本文链接的文献网络图示:

本文的引文网络